---
figid: PMC7859776__atm-09-01-38-f7
figlink: pmc/articles/PMC7859776/figure/f7/
number: Figure 7
caption: An illustrative model to show the proposed mechanism of miR-126-3p promoting
  sorafenib resistance in HCC. Sorafenib is a multikinase inhibitor which acts against
  several receptor tyrosine kinases, including PDGFR-β and VEGFR2, and then blocks
  the Raf/MEK/ERK signaling pathway. SPRED1 inhibits MEK/ERK activation by forming
  a complex with Raf. However, miR-126-3p can directly inhibit SPRED1 expression and
  then activate the ERK signaling pathway, thus impairing the anti-tumor effect of
  sorafenib against HCC. Taken together, inhibiting miR-126-3p could enhance sorafenib
  sensitivity against HCC through synergistically suppressing the Raf/MEK/ERK signaling
  pathway.
pmcid: PMC7859776
papertitle: miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma
  via downregulating SPRED1.
reftext: Wenliang Tan, et al. Ann Transl Med. 2021 Jan;9(1):38.
pmc_ranked_result_index: '22803'
pathway_score: 0.9462197
filename: atm-09-01-38-f7.jpg
figtitle: An illustrative model to show the proposed mechanism of miR-126-3p promoting
  sorafenib resistance in HCC
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7859776__atm-09-01-38-f7.html
  '@type': Dataset
  description: An illustrative model to show the proposed mechanism of miR-126-3p
    promoting sorafenib resistance in HCC. Sorafenib is a multikinase inhibitor which
    acts against several receptor tyrosine kinases, including PDGFR-β and VEGFR2,
    and then blocks the Raf/MEK/ERK signaling pathway. SPRED1 inhibits MEK/ERK activation
    by forming a complex with Raf. However, miR-126-3p can directly inhibit SPRED1
    expression and then activate the ERK signaling pathway, thus impairing the anti-tumor
    effect of sorafenib against HCC. Taken together, inhibiting miR-126-3p could enhance
    sorafenib sensitivity against HCC through synergistically suppressing the Raf/MEK/ERK
    signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - KDR
  - HRAS
  - KRAS
  - NRAS
  - SPRED1
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - FAM126A
  - sorafenib
genes:
- word: PDGFR-B
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SPRED1
  symbol: SPRED1
  source: hgnc_symbol
  hgnc_symbol: SPRED1
  entrez: '161742'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
chemicals:
- word: sorafenib
  source: MESH
  identifier: C471405
diseases: []
---
